… We wanted to compare the safety and effectiveness of oral antiplatelet therapy versus
placebo or no treatment in people with acute ischaemic stroke to see if oral antiplatelet drugs …

… potent antiplatelet agents. We focus this state-of-the-art review on the most recent advances
in oral antiplatelet therapy, … of dual antiplatelet therapy and future of personalized antiplatelet …

… coronary intervention receive antiplatelet therapy to reduce the risk … in individual responses
to oral antiplatelet therapy and its … Current guidelines recommend antiplatelet therapy with a …

Platelet-mediated thrombosis is a major pathophysiological mechanism that underlies acute
coronary syndromes, and therefore, antiplatelet therapy is an important foundation in the …

… for the clinical use of antiplatelet agents, to summarize the benefits and limitations of current
oral antiplatelet therapies, and to discuss novel approaches to oral antiplatelet therapy. …

… Oral antiplatelet therapy is central to the treatment of patients with thrombotic diseases. Yet,
… This has prompted the search for more efficacious oral antiplatelet agents. Drug classes that …

… safety of oral anticoagulation, with or without antiplatelet therapy, … trial to determine whether
oral anticoagulation (target … with antiplatelet therapy is superior to antiplatelet therapy alone …

… Cangrelor, abciximab, eptifibatide, and tirofiban are intravenous antiplatelet medications.
Because these are often used together with an oral antiplatelet regimen for treating acute …

… reactivity during treatment with established oral antiplatelet therapy has prompted the search
… This review highlights the rationale for important oral antiplatelet drugs in development and …

… We wanted to compare the safety and effectiveness of oral antiplatelet therapy versus placebo
or no treatment in people with acute ischaemic stroke to see if oral antiplatelet medicines …